The Asian Transcatheter Aortic Valve Replacement Registry
NCT ID: NCT02308150
Last Updated: 2019-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1505 participants
OBSERVATIONAL
2014-12-31
2019-09-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Asian Pacific TAVR Multicenter Registry
NCT02195102
The Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry
NCT02394184
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
NCT06381271
TAVR for Aortic Valve Disease
NCT05439863
The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis
NCT03163329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcatheter aortic valve replacement
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seung-jung Park, MD
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
Paul Hsien Li Kao, MD
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University
Shigeru Saito, MD
Role: PRINCIPAL_INVESTIGATOR
Shonan Kamakura General Hospital, Japan
Gerald Yong, MD
Role: PRINCIPAL_INVESTIGATOR
Royal Perth Hospital, Australia
Kentaro Hayashida, MD
Role: PRINCIPAL_INVESTIGATOR
Keio University, JAPAN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth Hospital
Hong Kong, , China
Shonan Kamakura General Hospital
Kamakura, , Japan
Kokura Memorial Hospital
Kitakyushu, , Japan
Keio University
Minato, , Japan
Teikyo University School of medicine
Tokyo, , Japan
Saiseikai Yokohama-city Eastern Hospital
Yokohama, , Japan
National University Heart Centre
Singapore, , Singapore
Asan Medical Center
Seoul, Songpa-gu, South Korea
Sejong Hospital
Bucheon-si, , South Korea
Chungnam National University Hospital
Daejeon, , South Korea
Seoul National University Hospital
Seoul, , South Korea
National Taiwan University
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yoon SH, Ahn JM, Hayashida K, Watanabe Y, Shirai S, Kao HL, Yin WH, Lee MK, Tay E, Araki M, Yamanaka F, Arai T, Lin MS, Park JB, Park DW, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Muramatsu T, Hanyu M, Kozuma K, Kim HS, Saito S, Park SJ; Asian TAVR Investigators. Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population. JACC Cardiovasc Interv. 2016 May 9;9(9):926-33. doi: 10.1016/j.jcin.2016.01.047.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV2014-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.